-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoDyn Reports Leronlimab Boosts PD-L1 and Extends Survival in Metastatic Triple-Negative Breast Cancer

Reuters·12/08/2025 13:30:58

Please log in to view news